Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
ÌÇÐÄ´«Ã½
A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors Lopez, J. S., Camidge, R., Iafolla, M., Rottey, S., Schuler, M., Hellmann, M., Balmanoukian, A., Dirix, L., Gordon, M., Sullivan, R., Henick, B. S., Drake, C., Wong, K., LoRusso, P., Ott, P., Fong, L., Schiza, A., Yachnin, J., Ottensmeier, C., Braiteh, F., Bendell, J., Leidner, R., Fisher, G., Jerusalem, G., Molenaar-Kuijsten, L., Schmidt, M., Laurie, S. A., Aljumaily, R., Rittmeyer, A., Gort, E., Melero, I., Mueller, L., Sabado, R., Twomey, P., Huang, J., Yadav, M., Zhang, J., Mueller, F., Derhovanessian, E., Sahin, U., Tuereci, O., Powles, T. AMER ASSOC CANCER RESEARCH. 2020View details for
View details for